PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $284,000 | -25.3% | 74,700 | 0.0% | 0.00% | – |
| Q4 2019 | $380,000 | -47.9% | 74,700 | -48.2% | 0.00% | -100.0% |
| Q3 2019 | $729,000 | -18.5% | 144,248 | -0.4% | 0.00% | 0.0% |
| Q2 2019 | $894,000 | +32.6% | 144,891 | -0.2% | 0.00% | 0.0% |
| Q1 2019 | $674,000 | -10.7% | 145,221 | -19.2% | 0.00% | 0.0% |
| Q4 2018 | $755,000 | -31.7% | 179,738 | +2.0% | 0.00% | 0.0% |
| Q3 2018 | $1,105,000 | -22.0% | 176,238 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $1,417,000 | +7.5% | 176,238 | -0.2% | 0.00% | 0.0% |
| Q1 2018 | $1,318,000 | +46.0% | 176,660 | +16.5% | 0.00% | +100.0% |
| Q4 2017 | $903,000 | -26.5% | 151,681 | -9.1% | 0.00% | -50.0% |
| Q3 2017 | $1,229,000 | -24.4% | 166,928 | -30.3% | 0.00% | 0.0% |
| Q2 2017 | $1,626,000 | -20.2% | 239,525 | +11.0% | 0.00% | -33.3% |
| Q1 2017 | $2,037,000 | +12.8% | 215,802 | +3.2% | 0.00% | 0.0% |
| Q4 2016 | $1,806,000 | +36.5% | 209,030 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $1,323,000 | +107.0% | 209,030 | +37.9% | 0.00% | +100.0% |
| Q2 2016 | $639,000 | -3.3% | 151,540 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $661,000 | -29.0% | 151,540 | -0.2% | 0.00% | 0.0% |
| Q4 2015 | $931,000 | +11.1% | 151,804 | +3.7% | 0.00% | 0.0% |
| Q3 2015 | $838,000 | -3.0% | 146,422 | +26.5% | 0.00% | 0.0% |
| Q2 2015 | $864,000 | +52.1% | 115,788 | +22.0% | 0.00% | 0.0% |
| Q1 2015 | $568,000 | – | 94,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |